Symptoms of ovarian hyperstimulation syndrome often begin within 10 days after using injectable medications to stimulate ovulation. Symptoms can range from mild to severe and may worsen or improve over time.
Mild to moderate OHSS
With mild to moderate ovarian hyperstimulation syndrome, symptoms can include:
- Mild to moderate abdominal pain that may come and go
- Abdominal bloating or increased waist size
- Tenderness in the area of your ovaries
Some women who use injectable fertility drugs get a mild form of OHSS, which goes away after about a week. If pregnancy occurs, however, symptoms of OHSS may worsen and last several days to weeks.
With severe ovarian hyperstimulation syndrome, you might have:
- Rapid weight gain — such as 5 pounds (2.3 kilograms) in one day or 10 pounds (4.5 kilograms) in three days or more
- Severe abdominal pain
- Severe, persistent nausea and vomiting
- Decreased urination
- Dark urine
- Shortness of breath
- Tight or enlarged abdomen
When to see a doctor
If you're having fertility treatments and you experience symptoms of ovarian hyperstimulation syndrome, tell your doctor. Even if you have a mild case of OHSS, your doctor will want to observe you for sudden weight gain or worsening symptoms.
Contact your doctor right away if you develop breathing problems or pain in your legs during your fertility treatment. This may indicate an urgent situation that needs prompt medical attention.
Feb. 14, 2014
- Gera PS, et al. Ovarian hyperstimulation syndrome: Steps to maximize success and minimize effect for assisted reproductive outcome. Fertility and Sterility. 2010;94:173.
- Insler V, et al. Pathogenesis of ovarian hyperstimulation syndrome. http://www.uptodate.com/home Accessed Sept. 23, 2013.
- Shaw RW, et al. Gynaecology. 4th ed. Edinburgh, U.K.: Churchill Livingstone; 2011. http://www.clinicalkey.com. Accessed Sept. 24, 2013.
- Vloeberghs V, et al. Ovarian hyperstimulation syndrome and complications of ART. Best Practice & Research Clinical Obstetrics and Gynaecology. 2009;23:691.
- Insler V, et al. Classification and treatment of ovarian hyperstimulation syndrome. http://www.uptodate.com/home. Accessed Sept. 23, 2013.
- Lentz GM, et al. Comprehensive Gynecology. 6th ed. Philadelphia, Pa.: Mosby Elsevier; 2012. http://www.clinicalkey.com. Accessed Sept. 24, 2013.
- Luke B, et al. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertility and Sterility. 2010;94:1399.
- Adams JG. Emergency Medicine: Clinical Essentials. 2nd ed. Philadelphia, Pa. Saunders Elsevier; 2013. http://www.clinicalkey.com. Accessed Sept. 24, 2013.
- Insler V, et al. Prevention of ovarian hyperstimulation syndrome. http://www.uptodate.com/home. Accessed Sept. 23, 2013.
- Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertility and Sterility. 2006;86:S178.
- Coddington CC (expert opinion). Mayo Clinic, Rochester, Minn. Oct. 2, 2013.
- Rollene NL, et al. Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: A case series. Fertility and Sterility. 2009;92:1169.e15.